Stocks & Investing
Tue, September 17, 2024
[ Tue, Sep 17th 2024
] - WOPRAI
Wed, August 7, 2024
[ Wed, Aug 07th 2024
] - WOPRAI
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Fri, July 26, 2024
[ Fri, Jul 26th 2024
] - WOPRAI
Thu, June 27, 2024
[ Thu, Jun 27th 2024
] - WOPRAI
Mon, June 24, 2024
[ Mon, Jun 24th 2024
] - WOPRAI
Thu, April 25, 2024
[ Thu, Apr 25th 2024
] - WOPRAI
Thu, April 18, 2024
[ Thu, Apr 18th 2024
] - WOPRAI
Fri, February 16, 2024
[ Fri, Feb 16th 2024
] - WOPRAI
Wed, February 14, 2024
[ Wed, Feb 14th 2024
] - WOPRAI
Tue, February 6, 2024
[ Tue, Feb 06th 2024
] - WOPRAI
[ Tue, Feb 06th 2024
] - WOPRAI
Mon, February 5, 2024
[ Mon, Feb 05th 2024
] - WOPRAI
Tue, January 2, 2024
[ Tue, Jan 02nd 2024
] - WOPRAI
Thu, November 9, 2023
[ Thu, Nov 09th 2023
] - WOPRAI
Fri, September 22, 2023
[ Fri, Sep 22nd 2023
] - WOPRAI
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
Wed, August 2, 2023
[ Wed, Aug 02nd 2023
] - WOPRAI
Fri, July 28, 2023
[ Fri, Jul 28th 2023
] - WOPRAI
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
Fri, April 28, 2023
[ Fri, Apr 28th 2023
] - WOPRAI
Mon, March 13, 2023
[ Mon, Mar 13th 2023
] - WOPRAI
Wed, February 1, 2023
[ Wed, Feb 01st 2023
] - WOPRAI
Tue, January 3, 2023
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
Mon, November 28, 2022
[ Mon, Nov 28th 2022
] - WOPRAI
Fri, October 28, 2022
[ Fri, Oct 28th 2022
] - WOPRAI
Wed, September 28, 2022
[ Wed, Sep 28th 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
Fri, May 6, 2022
[ Fri, May 06th 2022
] - WOPRAI
Mohit Bansal Maintained (BMRN) at Buy with Decreased Target to $90 on, Sep 17th, 2024
Mohit Bansal of Wells Fargo, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $115 to $90 on, Sep 17th, 2024.
Mohit has made no other calls on BMRN in the last 4 months.
There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Mohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
- Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024
These are the ratings of the 6 analyists that currently disagree with Mohit
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
- Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
